Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ZR2 BioenergyBOM:506640 +0.30%27 Return-on-Tangible-Equity is 0.57% as of Mar. 2026, which is 36% above its 10-year median of 0.42. GuruFocus rates BOM:506640 with a GF Score™ of 27/100. Among 1,570 Chemicals companies, ZR2 Bioenergy ranks worse than 71.85% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. ZR2 Bioenergy's annualized net income for the quarter that ended in Mar. 2026 was ₹7.96 Mil. ZR2 Bioenergy's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹1,399.70 Mil. Therefore, ZR2 Bioenergy's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 0.57%.
The historical rank and industry rank for ZR2 Bioenergy's Return-on-Tangible-Equity or its related term are showing as below:
BOM:506640'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -11.01 Med: 0.42 Max: 9.45
Current: 0.72
During the past 13 years, ZR2 Bioenergy's highest Return-on-Tangible-Equity was 9.45%. The lowest was -11.01%. And the median was 0.42%.
BOM:506640's Return-on-Tangible-Equity is ranked worse than 71.85% of 1570
companies
in the Chemicals industry
Industry Median: 5.88
vs BOM:506640: 0.72
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
ZR2 Bioenergy Return-on-Tangible-Equity Related Terms
ZR2 Bioenergy Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for ZR2 Bioenergy's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:506640 vs DOW: Return-on-Tangible-Equity Comparison
For the Chemicals subindustry, ZR2 Bioenergy's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ZR2 Bioenergy Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, ZR2 Bioenergy's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where ZR2 Bioenergy's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.57% mean?
ZR2 Bioenergy (BOM:506640) has a Return-on-Tangible-Equity of 0.57% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ZR2 Bioenergy and its competitors. This is 36% above median its historical median of 0.42. According to the industry distribution chart, ZR2 Bioenergy ranks #1128 out of 1570 companies in the Chemicals industry, placing it in the top 71.8%.
Is ZR2 Bioenergy's Return-on-Tangible-Equity too high?
ZR2 Bioenergy's current Return-on-Tangible-Equity of 0.57% is 36% above median its 10-year median of 0.42. The Chemicals industry median Return-on-Tangible-Equity is 5.88. ZR2 Bioenergy's value of 0.57% is 90.3% below this industry median. Based on the distribution chart, ZR2 Bioenergy ranks #1128 out of 1570 companies in the Chemicals industry, which is below the industry midpoint. Overall, ZR2 Bioenergy has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does ZR2 Bioenergy's Return-on-Tangible-Equity compare to DOW?
According to the Chemicals industry distribution chart, ZR2 Bioenergy ranks #1128 out of 1570 companies for Return-on-Tangible-Equity. This places ZR2 Bioenergy in the lower half of its industry. The industry median Return-on-Tangible-Equity is 5.88. ZR2 Bioenergy's value of 0.57% is 90.3% below this benchmark. While the company's 10-year median is 0.42 vs. the industry median of 5.88, ZR2 Bioenergy has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 5.88, based on 1,570 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ZR2 Bioenergy's current Return-on-Tangible-Equity of 0.57% is 90.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ZR2 Bioenergy and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ZR2 Bioenergy's current Return-on-Tangible-Equity is 0.57%, which is 36% above median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZR2 Bioenergy stock overvalued right now?
ZR2 Bioenergy (BOM:506640) has a current Return-on-Tangible-Equity of 0.57%. The current Return-on-Tangible-Equity is 0.57%, which is 36% above median its 10-year median of 0.42 and 90.3% below the Chemicals industry median of 5.88. ZR2 Bioenergy's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For ZR2 Bioenergy (BOM:506640), the current Return-on-Tangible-Equity is 0.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ZR2 Bioenergy Ltd is a chemical company. Its product portfolio includes Ethanol, Compressed Biogas, Bio-Potash, Carbon Credits, Alternative Protein, and a variety of human and animal nutrition products.
27GF Score
Get the complete analysis for BOM:506640
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506640 has been successfully added to your 
